Senate GOP eyes Medicare Advantage reforms as a way to pay for tax cuts
Senators see a crackdown on Medicare Advantage upcoding as a potential way to generate savings.
Related Articles
RFK Jr.’s chronic disease agency would eliminate or reduce funding for some prevention programs
Budget documents released Friday provide the first clear indication of the priorities of the proposed Administration for a Healthy America
As Omada goes public, executives reflect on why profits are elusive in digital health
Omada Health, a digital health company for 14 years supporting chronic disease patients, is yet to generate profits.
A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say the company’s…
Lawmakers lobby doctors to keep quiet — or speak up — on Medicaid cuts in Trump’s tax bill
GOP tells lobbyists for doctors Trump’s ‘Big, Beautiful Bill’ gives MDs a pay raise
We set out to quantify U.S. academic contributions to medicines. The results stunned even us
From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.
NIH details how Trump budget would cut support for grants, training, and research centers
President Trump’s 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions by 43%
We set out to quantify U.S. academic contributions to medicines. The results stunned even us
From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.
Do you remember the Human Genome Project? I’m not sure the Trump administration wants you to
The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.
RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
RFK Jr.’s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.
RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
RFK Jr.’s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.